Submission Details
| 510(k) Number | K200204 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 28, 2020 |
| Decision Date | April 06, 2020 |
| Days to Decision | 69 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K200204 is an FDA 510(k) clearance for the Stat Profile Prime Plus Analyzer System, a Oxyhemoglobin (Class II — Special Controls, product code GGZ), submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on April 6, 2020, 69 days after receiving the submission on January 28, 2020. This device falls under the Chemistry review panel. Regulated under 21 CFR 864.7500.
| 510(k) Number | K200204 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 28, 2020 |
| Decision Date | April 06, 2020 |
| Days to Decision | 69 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | GGZ — Oxyhemoglobin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7500 |